MARRADI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 7.763
EU - Europa 4.301
AS - Asia 2.888
SA - Sud America 803
AF - Africa 117
OC - Oceania 23
Totale 15.895
Nazione #
US - Stati Uniti d'America 7.626
RU - Federazione Russa 1.211
IT - Italia 1.177
CN - Cina 662
SG - Singapore 654
BR - Brasile 640
PL - Polonia 610
VN - Vietnam 491
HK - Hong Kong 431
IE - Irlanda 347
SE - Svezia 265
KR - Corea 249
CH - Svizzera 139
FR - Francia 121
FI - Finlandia 94
DE - Germania 85
ID - Indonesia 80
UA - Ucraina 75
CA - Canada 72
IN - India 72
AR - Argentina 70
JP - Giappone 62
BD - Bangladesh 53
GB - Regno Unito 53
MX - Messico 33
NG - Nigeria 32
NL - Olanda 26
CI - Costa d'Avorio 23
ES - Italia 22
AU - Australia 21
BG - Bulgaria 21
EC - Ecuador 21
CO - Colombia 20
TR - Turchia 20
IQ - Iraq 16
JO - Giordania 15
ZA - Sudafrica 15
BE - Belgio 12
PY - Paraguay 12
VE - Venezuela 11
AT - Austria 10
CL - Cile 10
MA - Marocco 10
PK - Pakistan 10
PE - Perù 9
EG - Egitto 8
TN - Tunisia 8
UY - Uruguay 8
AZ - Azerbaigian 7
MY - Malesia 6
SA - Arabia Saudita 6
TT - Trinidad e Tobago 6
BJ - Benin 5
CR - Costa Rica 5
IR - Iran 5
RO - Romania 5
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
JM - Giamaica 4
LB - Libano 4
OM - Oman 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
DK - Danimarca 3
GE - Georgia 3
GT - Guatemala 3
HN - Honduras 3
IL - Israele 3
KE - Kenya 3
KG - Kirghizistan 3
KW - Kuwait 3
KZ - Kazakistan 3
PH - Filippine 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CU - Cuba 2
CY - Cipro 2
EE - Estonia 2
KH - Cambogia 2
LT - Lituania 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
GF - Guiana Francese 1
GR - Grecia 1
HT - Haiti 1
HU - Ungheria 1
KI - Kiribati 1
Totale 15.882
Città #
Santa Clara 2.271
Ashburn 822
Fairfield 763
Warsaw 603
Singapore 507
Hong Kong 353
Dublin 344
Woodbridge 330
Seattle 316
Houston 284
Cambridge 266
Wilmington 234
Milan 228
Seoul 227
Florence 180
Ho Chi Minh City 175
Chandler 164
Beijing 155
Altamura 140
Lawrence 138
Bern 135
Ann Arbor 119
San Jose 119
Rome 114
Hanoi 110
Los Angeles 104
Hefei 96
Lauterbourg 92
Council Bluffs 85
Princeton 83
Jacksonville 76
Moscow 74
The Dalles 72
Boston 69
Buffalo 64
Tokyo 60
Clifton 52
São Paulo 50
Jakarta 44
San Diego 41
Medford 40
Helsinki 39
Mumbai 36
Lappeenranta 34
Abuja 32
New York 30
Dallas 28
Shanghai 27
Boardman 25
Abidjan 23
Haiphong 23
Naples 23
Norwalk 22
Rio de Janeiro 22
Sofia 21
Dong Ket 20
Melbourne 20
Turin 19
Chicago 18
Figino 18
Kent 18
Curitiba 17
Da Nang 17
Toronto 17
Belo Horizonte 16
Atlanta 15
Bologna 15
Munich 15
Dearborn 14
Palermo 14
Phoenix 14
Andover 13
Barcelona 13
Campinas 13
Miano 13
Shenzhen 13
Stockholm 13
Biên Hòa 12
Brasília 12
Genoa 12
Guangzhou 12
Montreal 12
Orem 12
Bogotá 11
Redondo Beach 11
Arezzo 10
Baghdad 10
Brussels 10
Falls Church 10
Frankfurt am Main 10
London 10
Vienna 10
Bengaluru 9
Hải Dương 9
Porto Alegre 9
Quito 9
Yubileyny 9
Buenos Aires 8
Catania 8
Hillsboro 8
Totale 11.162
Nome #
Synthesis of densely functionalized enantiopure indolizidines by ring-closing metathesis (RCM) of hydroxylamines from carbohydrate-derived nitrones 321
A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection 276
The B & B approach: Ball-milling conjugation of dextran with phenylboronic acid (PBA)-functionalized BODIPY 272
Fabrication of hybrid graphene oxide/polyelectrolyte capsules by means of layer-by-layer assembly on erythrocyte cell templates 250
Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities 243
GNP-GAPDH1-22 nanovaccines prevent neonatal listeriosis by blocking microglial apoptosis and bacterial dissemination 232
Biocompatible single-chain polymer nanoparticles loaded with an antigen mimetic as potential anticancer vaccine 229
On the Virtue of Indium in Reduction Reactions. A Comparison of Reductions Mediated by Indium and Zinc: Is Indium Metal an Effective Catalyst for Zinc Induced Reductions? 226
Multimerization of DAB-1 onto Au GNPs affords new potent and selective N-acetylgalactosamine-6-sulfatase (GALNS) inhibitors 226
A new ex vivo method to evaluate the performance of candidate MRI contrast agents: a proof-of-concept study 217
Glycosystems in nanotechnology: Gold glyconanoparticles as carrier for anti-HIV prodrugs 211
Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells 209
Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses 205
Formal Mixed Double Addition to N-Glycosyl Nitrones through Addition–Oxidation–Addition to N-Glycosylhydroxylamines 204
High sensitive detection of carbohydrate binding proteins in an ELISA-solid phase assay based on multivalent glyconanoparticles 203
Preparation and immunogenicity of gold glyco-nanoparticles as antipneumococcal vaccine model 201
Gold nanoparticles decorated with monosaccharides and sulfated ligands as potential modulators of the lysosomal enzyme N-acetylgalactosamine-6-sulfatase (GALNS) 191
Carbohydrate-based nanoparticles for potential applications in medicine 186
Glyconanoparticles: multifunctional nanomaterials for biomedical applications 183
Double Addition of Grignard Reagents to N-Glycosyl Nitrones: a New Tool for the Construction of Enantiopure Azaheterocycles 182
Glycoliposomes and metallic glyconanoparticles in glycoscience 182
Assembling different antennas of the gp120 high mannose-type glycans on gold nanoparticles provides superior binding to the anti-HIV antibody 2G12 than the individual antennas 182
Cytotoxicity testing of therapeutic nanosystems for pulmonary infection using an air-lifted interphase in-vitro test system 182
Hybrid Multivalent Jack Bean alpha-Mannosidase Inhibitors: The First Example of Gold Nanoparticles Decorated with Deoxynojirimycin Inhitopes 181
Functional Single-Chain Polymer Nanoparticles: Targeting and Imaging Pancreatic Tumors in Vivo 179
Practical Synthesis of N-Alkyl-N-glycosylhydroxylamines, Multitalented Precursors of Enantiomerically Pure Nitrones 178
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 177
N-Glycosylhydroxylamines as masked polyhydroxylated chiral nitrones in cycloaddition reactions: an access to pyrrolizidines 175
A quantitative study of the intracellular dynamics of fluorescently labelled glyco-gold nanoparticles via fluorescence correlation spectroscopy 174
Dissecting the carbohydrate specificity of the anti-HIV-1 2G12 antibody by single-molecule force spectroscopy 174
Gold manno-glyconanoparticles for intervening in HIV gp120 carbohydrate-mediated processes 174
Glyconanoparticles as multifunctional and multimodal carbohydrate systems 173
Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents 169
Gold nanoparticles are suitable cores for building tunable iminosugar multivalency 168
Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine 166
A solution NMR study of the interactions of oligomannosides and the anti-HIV-1 2G12 antibody reveals distinct binding modes for branched ligands 165
Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma 164
Manganese Dioxide Oxidation of Hydroxylamines to Nitrones 163
Carbohydrate Functionalized Quantum Dots in Sensing, Imaging and Therapy Applications 161
Gold Nanoparticles as Carriers for Synthetic Glycoconjugate Vaccines 160
In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection 160
Coloranti naturalizzati: una nuova opportunità per la colorazione del legno 159
Chapter 5. Glyconanotechnology and Disease: Gold Nanoparticles Coated with Glycosides as Multivalent Systems for Potential Applications in Diagnostics and Therapy 159
Galactofuranose-coated gold nanoparticles elicit a pro-inflammatory response in human monocyte-derived dendritic cells and are recognized by DC-SIGN 159
Novel Core–Shell Polyamine Phosphate Nanoparticles Self-Assembled from PEGylated Poly(allylamine hydrochloride) with Low Toxicity and Increased In Vivo Circulation Time 159
Novel nanoparticle vaccines for Listeriosis 158
Recent advances on smart glycoconjugate vaccines in infections and cancer 157
Loading Dendritic Cells with Gold Nanoparticles (GNPs) Bearing HIV-peptides and Mannosides Enhance HIV-specific T Cell Responses 157
Molybdenum Hexacarbonyl [Mo(CO)6] 156
Sugar/gadolinium-loaded gold nanoparticles for labelling and imaging cells by magnetic resonance imaging 155
Naturalized Dyes: A New Opportunity for the Wood Coloring 154
Supramolecular dextran/polyamine phosphate nanocapsules with smart responsiveness for encapsulation of therapeutics 153
A PROCESS FOR PREPARING WATER-DISPERSIBLE SINGLE-CHAIN POLYMERIC NANOPARTICLES 153
Visualisation of dual radiolabelled poly(lactide-co-glycolide) nanoparticle degradation in vivo using energy-discriminant SPECT 153
Synthesis and functionalization of dextran-based single-chain nanoparticles in aqueous media 151
Radiolabelling of NPs Using Radiometals: 99mTc, 68Ga, 67Ga, 89Zr, and 64Cu 151
Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN 149
Multivalent glycoconjugates as anti-pathogenic agents 148
Interfacial activity of modified Dextran polysaccharide to produce enzyme-responsive oil-in-water nanoemulsions 148
Recent developments in the reduction of oxidative stress through antioxidant polymeric formulations 147
Influence of ligand presentation density on the molecular recognition of mannose-functionalised glyconanoparticles by bacterial lectin BC2L-A 147
Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma 147
Simple engineering of hybrid cellulose nanocrystal-gold nanoparticles results in a functional glyconanomaterial with biomolecular recognition properties 146
Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12 146
Multivalent iminosugars as enhancers of the lysosomal enzyme GCase activity 144
Paramagnetic Gd-based gold glyconanoparticles as probes for MRI: tuning relaxivities with sugars 144
Radiolabelling of Nanoparticles Using Radiohalogens, 13N, and 11C 144
Nano-antibiotics based on single-chain dextran nanoparticles 144
New Highly Strained Multifunctional Heterocycles by Intramolecular Cycloaddition of Nitrones to Bicyclopropylidene Moieties 143
Glyconanoparticles: New Nanomaterials for Biological Applications 143
STD NMR study of the interactions between antibody 2G12 and synthetic oligomannosides that mimic selected branches of gp120 glycans 143
MULTIVALENT VACCINE FOR THE TREATMENT AND PREVENTION OF TUBERCULOSIS, LISTERIOSIS AND PNEUMONIA 143
In vivo stability of protein coatings on poly lactic co glycolic nanoparticles 142
Gold Glyconanoparticles Combined with 91–99 Peptide of the Bacterial Toxin, Listeriolysin O, Are Efficient Immunotherapies in Experimental Bladder Tumors 142
Nucleophilic Additions to Cyclic Nitrones en route to Iminocyclitols - Straightforward Total Syntheses of DMDP, 6-deoxy-DMDP, DAB-1, CYB-3, Nectrisine, and Radicamine B 141
Neutralization of ionic interactions by dextran-based single-chain nanoparticles improves tobramycin diffusion into a mature biofilm 141
Multivalent gold glycoclusters: high affinity molecular recognition by bacterial lectin PA-IL 140
Emerging glyco-based strategies to steer immune responses 138
New Oligocyclic beta-Lactams and beta-Amino Acids by Intramolecular Cycloaddition of Bicyclopropylidenyl-Substituted Nitrones 137
Preparation of N-Glycosylhydroxylamines and Their Oxidation to Nitrones for the Enantioselective Synthesis of Isoxazolidines 134
Straightforward Synthesis of Enantiopure 2-Aminomethyl and 2-Hydroxymethyl Pyrrolidines with Complete Stereocontrol 134
Therapeutic efficacy of novel antimicrobial peptide AA139-nanomedicines in a multidrug-resistant klebsiella pneumoniae pneumonia-septicemia model in rats 134
Gold Nanoparticles as Scaffolds for the Multimerization of Iminosugars: New Multivalent Modulators of the Enzyme GCase 133
USE OF A GNP-LLO91-99 COMPLEX FOR THE TREATMENT AND PREVENTION OF CANCER 131
Low-generation dendrimers with a calixarene core and based on a chiral C2-symmetric pyrrolidine as iminosugar mimics 130
Glycan-stabilized plasmonic nanoparticles: An attractive nanomaterial for bio-applications 129
Glyconanoparticles polyvalent tools to study carbohydrate-based interactions 128
New chiral nitrones for stereoselective syntheses of biologically active natural products and their analogues 125
One-Pot Synthesis of Cyclic Nitrones and Their Conversion to New Pyrrolizidines: 7a-epi-Crotanecine Inhibits α-Mannosidases 122
New multivalent glycosidase inhibitors: exploring different iminosugars and scaffolds 113
Multivalent GCase enhancers: synthesis and evaluation of glyco- gold nanoparticles decorated with trihydroxypiperidine iminosugars 108
Dual-Targeting Gold Nanoparticles: Simultaneous Decoration with Ligands for Co-Transporters SGLT-1 and B0AT1 107
Multivalent 2-alkyl trihydroxypiperidines as potential enhancers of the β-glucocerebrosidase enzyme activity 104
Gold nanoparticles and lipid vesicles: a gateway to advanced nanoplasmonic and SERS probes for biomedical applications 90
Galactose‐Functionalized Gold Nanoparticles Targeting Membrane Transporters for the Glutathione Delivery to Brain Cancer Cells 65
Tobramycin nanoformulation for chronic pulmonary infections: From drug product definition to scale-up for preclinical evaluation 62
Engineering biomimetic lipid interfaces to form smart materials 49
Multivalent sugars and glycomimetics as enzyme stabilizers for lysosomal storage diseases 48
Glyconanocapsules with pH Responsiveness for Encapsulation and Smart Delivery of Therapeutics 47
Dextran-Modified Poly(allylamine) Nanoparticles as Nanocarriers for the Delivery of Enzymes involved in Lysosomal Storage Diseases 46
Totale 15.854
Categoria #
all - tutte 42.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022635 26 47 80 29 14 41 55 39 34 31 72 167
2022/20231.433 177 354 65 50 54 219 201 48 86 6 34 139
2023/2024414 17 41 105 20 37 40 18 56 7 37 24 12
2024/20254.541 117 361 204 469 1.466 1.138 82 281 105 70 117 131
2025/20265.317 385 600 441 866 434 150 535 338 345 341 151 731
2026/2027187 187 0 0 0 0 0 0 0 0 0 0 0
Totale 16.171